Concepedia

Author

HIROSHI YAMAGA

Sumitomo Dainippon Pharma (Japan)

Also Known As

HIROSHI YAMAGA, Hiroshi YAMAGA, Hiroshi Yamaga

13

Publications

184

Citations

8

H-Index

9

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)Sumitomo Chemical (United States)
HY

About

HIROSHI YAMAGA is an author at Sumitomo Dainippon Pharma (Japan) specializing in pharmacology, biochemistry, and inorganic chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Biochemistry

2

2

41

2

Engineering

1

1

65

3

Medicine

1

1

12

4

Chemistry

1

1

65

5

Materials Science

1

1

65

HIROSHI YAMAGA

×

6

Publications

143

Citations

6

H-Index

YearCitations

Specific extraction behavior of amide derivative of calix[4]arene for silver (I) and gold (III) ions from highly acidic chloride media

Keisuke Ohto, HIROSHI YAMAGA, Emi Murakami,

Talanta

1997

65

Synthesis and biological properties of a new series of anti-MRSA β-lactams; 2-(thiazol-2-ylthio)carbapenems

HISATOSHI SHINAGAWA, HIROSHI YAMAGA, Hitoshi Houchigai,

Bioorganic & Medicinal Chemistry

1997

29

Synthesis and biological properties of 1.BETA.-methyl-carbapenems with N-methylpyrrolidinylthio group at C-2 position.

Makoto Sunagawa, HARUKI MATSUMURA, TAKAAKI INOUE,

The Journal of Antibiotics

1992

16

Synthesis and biological properties of a new series of anti-MRSA β-lactams; 2-(thiazol-2′-ylthio)carbapenems

Makoto Sunagawa, HIROSHI YAMAGA, HISATOSHI SHINAGAWA,

Bioorganic & Medicinal Chemistry Letters

1994

12

The effect of 1.BETA.-methyl and imidoyl substituents on the antipseudomonal activity of carbapenems.

Yoshihiro Sumita, Yoko Eguchi, MASATOMO FUKASAWA,

The Journal of Antibiotics

1993

11

The Effect of 1.BETA.-Methyl Substituent and the Basicity in C-2 Side Chain in Carbapenem Antibiotics on the Activity against Pseudomonas aeruginosa oprD2 and nalB Mutants.

Yoshihiro Sumita, HIROSHI YAMAGA, Makoto Sunagawa

The Journal of Antibiotics

1995

10

Page 1